Brief information about it:
Elvitegravir is an integrase inhibitor (INHI) medication used to treat HIV/AIDS.
Uses:
Treatment of HIV-1 infection
Mechanism of action:
Elvitegravir inhibits the integrase enzyme, preventing the HIV virus from integrating its genetic material into the host cell’s DNA.
Elimination half life:
Approximately 14 hours
Route of Administration:
Oral (tablets)
Side effects:
Common side effects include:
- Diarrhea
- Nausea
- Fatigue
- Headache
- Insomnia
Dose:
The dosage of elvitegravir varies depending on the individual and the specific treatment regimen. It’s often used in combination with other antiretroviral drugs.
Precautions:
· Drug interactions
· Potential for hypersensitivity reactions
